Telemedicine for Hematology During COVID-19 and Beyond
The benefits of telemedicine became more evident in the context of the elevated risk of COVID-19 infection and severe symptoms among the patients served by hematology and oncology practices.
The benefits of telemedicine became more evident in the context of the elevated risk of COVID-19 infection and severe symptoms among the patients served by hematology and oncology practices.
In this interview, Richard Becker, MD, gives us an insight into COVID-19 vasculitis and its manifestations.